Combined therapy using BRAF and MEK inhibitor seems to show a greater efficacy in the magnitude of reduction in tumor volume and in terms of rapidity of action compared to single-agent treatment (5, 16, 18, 19, 23, 26, 27). This evidence concerns the gene BRAF and neoplasm.